Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction

Biochemical Pharmacology

Volumn 59, Issue 3, 2000, Pages 293-300

  Ax, Wolfram ^a   Soldan, Michael ^a   Koch, Lutz ^a   Maser, Edmund ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cancer cells; Carbonyl reduction; Daunorubicin; Induction; Resistance

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALDEHYDE REDUCTASE; CARBONYL DERIVATIVE; CARBONYL REDUCTASE; DAUNORUBICIN; DIHYDRODIOL DEHYDROGENASE; DRUG METABOLITE; GLUTATHIONE TRANSFERASE; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL;

ARTICLE; CELL SELECTION; DETOXIFICATION; DRUG DETERMINATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCTION; TUMOR CELL;

ALCOHOL OXIDOREDUCTASES; ANTIBIOTICS, ANTINEOPLASTIC; ATP-BINDING CASSETTE TRANSPORTERS; DAUNORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HUMANS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OXIDATION-REDUCTION; P-GLYCOPROTEIN; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0033988708     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00322-6     Document Type: Article

References (51)

1. Endicott J.A., Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 58:1989;137-171.
2. Zaman G.J., Flens M.J., van Leusden M.R., de Haas M., Mülder H.S., Lankelma J., Pinedo H.M., Scheper R.J., Baas F., Broxterman H.J., Borst P. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA. 91:1994;8822-8826.
3. Scheffer G.L., Wijngaard P.L., Flens M.J., Izquierdo M.A., Slovak M.L., Pinedo H.M., Meijer C.J., Clevers H.C., Scheper R.J. The drug resistance-related protein LRP is the human major vault protein. Nat Med. 1:1995;578-582.
4. Deffie A.M., Alam T., Seneviratne C., Beenken S.W., Batra J.L., Shea T.C., Henner W.D., Goldenberg G.J. Multifactorial resistance to adriamycin Relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia . Cancer Res. 48:1988;3595-3602.
5. Kramer R.A., Zakher J., Kim G. Role of glutathione redox cycle in acquired and de novo multidrug resistance. Science. 241:1988;694-697.
6. Gessner T., Vaughan L.A., Beehler B.C., Bartels C.J., Baker R.M. Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells. Cancer Res. 50:1990;3921-3927.
7. Batist G., Tulpule A., Sinha B.K., Katki A.G., Myers G.E., Cowan K.H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem. 261:1986;15544-15549.
8. Capranico G., Riva A., Tinelli S., Dasdia T., Zunino F. Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei. Cancer Res. 47:1987;3752-3756.
9. Volm M., Mattern J., Efferth T., Pommerenke E.W. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas. Anticancer Res. 12:1992;1063-1067.
10. Rekha G.K., Sreerama L., Sladek N.E. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase. Biochem Pharmacol. 48:1994;1943-1952.
11. Inoue S., Sharma R.C., Schimke R.T., Simoni R.D. Cellular detoxification of tripeptidyl aldehydes by an aldo-keto reductase. J Biol Chem. 268:1993;5894-5898.
12. Toffoli G., Simone F., Gigante M., Boiocchi M. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines. Biochem Pharmacol. 48:1994;1871-1881.
13. McGrath T., Center M.S. Adriamycin resistance in HL60 cells in absence of detectable P-glycoprotein. Biochem Biophys Res Commun. 145:1987;1171-1176.
14. Ramachandran C., Yuan Z.K., Huang X.L., Krishan A. Doxorubicin resistance in human melanoma cells MDR-1 and glutathione S-transferase II gene expression . Biochem Pharmacol. 45:1993;743-751.
15. Soldan M., Netter K.J., Maser E. Induction of daunorubicin carbonyl reducing enzymes by daunorubicin in sensitive and resistant pancreas carcinoma cells. Biochem Pharmacol. 51:1996;117-123.
16. Soldan M., Netter K.J., Maser E. Enzymatic detoxification of daunorubicin as supplementary mechanism to multidrug resistance. Exp Toxic Path. 48:(Suppl II):1996;370-376.
17. Schott B., Robert J. Comparative activity of anthracycline 13-hydroxymetabolites against rat glioblastoma cells in culture. Biochem Pharmacol. 38:1989;4069-4074.
18. Ozols R.F., Willson J.K., Weltz M.D., Grotzinger K.R., Myers C.E., Young R.C. Inhibition of human ovarian cancer colony formation by adriamycin and its major metabolites. Cancer Res. 40:1980;4109-4117.
19. Dessypris E.N., Brenner D.E., Hande K.R. Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitro. Cancer Treat Rep. 70:1986;487-490.
20. Olson R.D., Mushlin P.S., Brenner D.E., Fleischer S., Cusack B.J., Chang B.K., Boucek R.J. Jr. Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc Natl Acad Sci USA. 85:1988;3585-3589.
21. Beran M., Andersson B., Eksborg S., Ehrsson H. Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUC) by daunorubicin, daunorubicinol and daunorubicin-DNA complex. Cancer Chemother Pharmacol. 2:1979;19-24.
22. Yesair M., Thayer P.S., McNitt S., Teague K. Comparative uptake, metabolism and retention of anthracyclines by tumors growing in vitro. Eur J Cancer. 16:1980;901-907.
23. Kuffel M.J., Reid J.M., Ames M.M. Anthracyclines and their C-13 alcohol metabolites Growth inhibition and DNA damage following incubation with human tumor cells in culture . Cancer Chemother Pharmacol. 30:1992;51-57.
24. Ohara H., Miyabe Y., Deyashiki Y., Matsuura K., Hara A. Reduction of drug ketones by dihydrodiol dehydrogenases, carbonyl reductase and aldehyde reductase of human liver. Biochem Pharmacol. 50:1995;221-227.
25. Hyndman D.J., Takenoshita R., Vera N.L., Pang S.C., Flynn T.G. Cloning, sequencing, and enzymatic activity of an inducible aldo-keto reductase from Chinese hamster ovary cells. J Biol Chem. 272:1997;13286-13291.
26. Muller C., Bailly J.D., Goubin F., Laredo J., Jaffrezou J.P., Bordier C., Laurent G. Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines. Int J Cancer. 56:1994;749-754.
27. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41:1981;1967-1972.
28. Hansen M.B., Nielsen S., Berg K. Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 119:1989;203-210.
29. Habig W.H., Jakoby W.B. Glutathione S-transferases (rat and human). Methods Enzymol. 77:1981;218-231.
30. Dutton G.J., Leakey J.E., Pollard M.R. Assays for UDP-glucuronyltransferase activities. Methods Enzymol. 77:1981;383-391.
31. Zhu B.T., Suchar L.A., Gwynne M., Huang M.T. Effect of age and sex on the inducibility of hepatic microsomal 4-nitrophenol UDP-glucuronyltransferase activity in rats. Life Sci. 57:1995;19-24.
32. Diamond G., Quebbemann A.J. Rapid separation of p-nitrophenol and its glucuronide and sulfate conjugates by reversed-phase high-performance liquid chromatography. J Chromatograph. 177:1979;368-371.
33. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurements with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
34. Vasanthakumar G., Ahmed N.K. Comparative uptake, retention and cytotoxicity of daunorubicin by human myeloid cells. Biochem Pharmacol. 35:1986;1185-1190.
35. Huffman D.H., Bachur N.R. Daunorubicin metabolism in acute myelocytic leukemia. Blood. 39:1972;637-643.
36. Goren M.P., Ahmed N.K., Tereba A. Use of somatic cell hybrids to analyze role of specific enzymes in daunorubicin cytotoxicity. Cancer Res. 47:1987;1924-1929.
37. Gonzalez B., Akman S., Doroshow J., Rivera H., Kaplan W.D., Forrest G.L. Protection against daunorubicin cytotoxicity by expression of a cloned human carbonyl reductase cDNA in K562 leukemia cells. Cancer Res. 55:1995;4646-4650.
38. Soldan M., Ax W., Koch L., Plebuch M., Maser E. Cytostatic drug resistance Role of phase-I daunorubicin metabolism in cancer cells . Adv Exp Med Biol. 463:1999;529-538.
39. Schisselbauer J.C., Crescimanno M., D'Alessandro N., Clapper M., Toulmond S., Tapiero H., Tew K.D. Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype. Cancer Commun. 1:1989;133-139.
40. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:1994;4313-4320.
41. Peters W.H., Roelofs H.M. Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells A possible role for glutathione S-transferases . Cancer Res. 52:1992;1886-1890.
42. Gajewska J., Szczypka M., Izbicki T., Klepacka T., Laskowska-Klita T. Antioxidant and glutathione-associated enzymes in Wilms' tumour after chemotherapy. J Cancer Res Clin Oncol. 122:1996;483-488.
43. Strohmeyer T., Klöne A., Wagner G., Hartmann M., Sies H. Glutathione S-transferases in human testicular germ cell tumors Changes of expression and activity . J Urol. 147:1992;1424-1428.
44. Bohren K.M., Bullock B., Wermuth B., Gabbay K.H. The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem. 264:1989;9547-9551.
45. Persson B., Krook M., Jornvall H. Characteristics of short-chain alcohol dehydrogenases and related enzymes. Eur J Biochem. 200:1991;537-543.
46. Bors W., Heller W., Michel C., Saran M. Flavonoids as antioxidants Determination of radical-scavenging efficiencies . Methods Enzymol. 186:1990;343-355.
47. Wermuth B. Aldo-keto reductases. Flynn T.G., Weiner H. Enzymology of Carbonyl Metabolism Aldehyde Dehydrogenase, Aldo/Keto Reductase, and Alcohol Dehydrogenase . 1985;209-230 Alan R. Liss, New York.
48. Inazu N., Ruepp B., Wirth H., Wermuth B. Carbonyl reductase from human testis Purification and comparison with carbonyl reductase from human brain and rat testis . Biochim Biophys Acta. 1116:1992;50-56.
49. Shapiro A.B., Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol. 53:1997;587-596.
50. Scambia G., Ranelletti F.O., Panici P.B., DeVincenzo R., Bonanno G., Ferrandina G., Piantelli M., Bussa S., Rumi C., Cianfriglia M., Manusco S. Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line P-glycoprotein as a possible target . Cancer Chemother Pharmacol. 34:1994;459-464.
51. Ahmed N.K., Felsted R.L., Bachur N.R. Heterogeneity of anthracycline antibiotic carbonyl reductases in mammalian livers. Biochem Pharmacol. 27:1978;2713-2719.